Video

Dr. David Albala on The Role of Robotic Surgery in Prostate Cancer

David Albala, MD, urologist and medical director, Associated Medical Professionals, spoke with OncLive about the role and benefits of robotic surgery in prostate cancer during the LUGPA Annual Meeting.

Robotic surgery has a firm implant in urological surgery, especially in oncology, with prostatectomy and cystectomy procedures, Albala says.

The benefits of robotic surgery for patients include a quicker recovery time, less pain, and less blood loss. The complications are also very similar to what is seen in open surgery.

Patients undergoing a prostatectomy via robotic surgery are typically out of the hospital in one week, Albala says.

Related Videos
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Louis Crain Garrot, MD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Bradley C. Carthon, MD, PhD
Fred Saad, CQ, MD, FRCS, FCAHS, director, Prostate Cancer Research, Montreal Cancer Institute, Centre Hospitalier de l’Université de Montréal; full professor, Department of Surgery, Université de Montréal; uro-oncologist, Urology Department, University of Montreal Health Center